Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
Oncotarget. 2015 Aug 19;
Distinct Pathways in the Pathogenesis of Sebaceous Carcinomas Implicated by Differentially Expressed MicroRNAs.
JAMA Ophthalmol. 2015 Jul 23;
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.
Mod Pathol. 2015 Jun 26;
Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice.
Clin Cancer Res. 2015 Jun 23;
DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
Acta Neuropathol Commun. 2015;3:34
Acta Neuropathol. 2015 Jun 19;
Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations.
Hum Pathol. 2015 Apr 15;
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.
Cancer Cell. 2015 May 11;27(5):728-43
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
Acta Neuropathol. 2015 May 12;
Acta Neuropathol. 2015 May 6;